You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 Comparison of demographics and clinical features of DF and DHF

From: Clinico-laboratory spectrum of dengue viral infection and risk factors associated with dengue hemorrhagic fever: a retrospective study

  Overall Cases (N = 667) n (%) DF (N = 588) n (%) DHF (N = 79) n (%) P–value*
Age > 40 years 167 (25) 137 (23.3) 30 (38) 0.005
Male gender 378 (56.7) 326 (55.4) 52 (55.8) 0.08
Urban resident 403 (60.4) 346 (41.2) 57 (72.2) 0.023
Temperature > 38 Co 229 (34.3) 197 (33.5) 32 (40.5) 0.218
Obesity 94 (14.1) 82 (13.2) 12 (15.2) 0.467
Co-morbidities     
 DM 36 (5.4) 13 (2.2) 23 (29.1) 0.001
 HTN 35 (5.2) 17 (2.9) 18 (22.4) 0.021
 CKD 33 (4.9) 26 (4.4) 7 (8.9) 0.085
 IHD 25 (3.7) 19 (3.2) 6 (7.6) 0.178
 CHF 2 (0.3) 2 (0.3) 0 (0) -
 HPL 8 (1.2) 7 (1.2) 1 (1.3) 0.649
Risk group associationa 264 (39.6) 232 (39.5) 32 (40.5) 0.858
Secondary infection 73 (10.9) 58 (9.9) 18 (22.8) 0.015
Warning signs 271 (40.6) 224 (38.1) 47 (59.7) 0.000
Positive Hess test 101 (15.1) 85 (14.5) 16 (20.3) 0.177
Low MAP 37 (5.5) 34 (5.8) 3 (3.8) 0.469
Elevate Scr (AKI) 95 (14.2) 58 (9.9) 37 (65.8) 0.000
Thrombocytopenia 395 (59.2) 343 (58.3) 56 (70.8) 0.042
Leukopenia 363 (54.4) 321 (54.6) 42 (53.2) 0.596
Leukocytosis 36 (5.4) 32 (5.4) 4 (5.1) 0.842
Elevated ALT 362 (54.3) 315 (53.6) 47 (59.5) 0.321
Elevated AST 447 (67) 380 (64.6) 67 (84.8) 0.000
Elevated ALP 113 (19.9) 117 (19.9) 16 (20.3) 0.885
Transaminitis 360 (54) 311 (52.9) 49 (62) 0.125
Rhabdomyolosis 49 (7.3) 34 (5.8) 15 (19) 0.000
Multiple organ dysfunctions 138 (20.7) 97 (16.5) 43 (54.4) 0.000
Urinary sedimentations 96 (14.4) 78 (13.3) 18 (22.8) 0.034
Hemoconcentration 73 (10.9) 56 (9.5) 17 (21.5) 0.001
Prolonged PT and aPTT 116 (17.4) 93 (15.6) 23 (29.1) 0.003
Delayed Hospitalization (>3 days of onset of illness) 153 (22.9) 105 (17.9 %) 48 (60.8) 0.000
Death 8 (1.2) 6 (1) 2 (2.5) 0.243
  1. *Chi-Square/Fisher’s Exact test, where appropriate, adefined as number of patients having association of dengue infection risk groups as described under results section